Cargando…
Utilization and Potential of RNA-Based Therapies in Cardiovascular Disease
Cardiovascular disease (CVD) remains the largest cause of mortality worldwide. The development of new effective therapeutics is a major unmet need. The current review focuses broadly on the concept of nucleic acid (NA)–based therapies, considering the use of various forms of NAs, including mRNAs, mi...
Autores principales: | Robinson, Emma Louise, Port, J. David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617127/ https://www.ncbi.nlm.nih.gov/pubmed/36317129 http://dx.doi.org/10.1016/j.jacbts.2022.02.003 |
Ejemplares similares
-
Sarcopenia and Cardiovascular Diseases
por: Damluji, Abdulla A., et al.
Publicado: (2023) -
Small non-coding RNA therapeutics for cardiovascular disease
por: Shah, Ajay M, et al.
Publicado: (2022) -
Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options
por: Jankowski, Joachim, et al.
Publicado: (2021) -
COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases
por: Zhang, Yuanyuan, et al.
Publicado: (2021) -
Therapeutic and Diagnostic Translation of Extracellular Vesicles in Cardiovascular Diseases: Roadmap to the Clinic
por: Sahoo, Susmita, et al.
Publicado: (2021)